nalmefene and Addiction, Opioid

nalmefene has been researched along with Addiction, Opioid in 12 studies

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (33.33)18.2507
2000's2 (16.67)29.6817
2010's5 (41.67)24.3611
2020's1 (8.33)2.80

Authors

AuthorsStudies
Adapa, ID; Auh, JS; Berzetei-Gurske, IP; Brandt, SR; Craymer, K; Farrington, L; Haggart, D; Kennedy, JM; O'Brien, A; Polgar, WE; Rodriguez, L; Schwartz, RW; Toll, L; White, A1
Kunzler, NM; Nelson, LS; Wightman, RS1
Franchitto, N; Jullian, B; Pelissier, F; Rolland, B; Salles, J1
Donnerstag, N; Lüthi, A; Mehlig, A; Raetz Bravo, A; Schneider, T; Taegtmeyer, A1
Dahmke, H; Kullak-Ublick, GA; Kupferschmidt, H; Weiler, S1
Franchitto, N; Nubukpo, P; Pélissier, F; Rougé Bugat, ME1
Ali, R; Gowing, L; White, JM1
Cottone, P; Sabino, V; Steardo, L; Zorrilla, EP1
Chami, TN; Cheskin, LJ; Jaffe, JH; Johnson, RE1
Litten, RZ1
Cullen, DJ; Dwyer, MJ; Gold, CG; Gonzales, S; Houtmeyers, D1
Fudala, PJ; Heishman, SJ; Henningfield, JE; Johnson, RE; Jones, HE1

Reviews

3 review(s) available for nalmefene and Addiction, Opioid

ArticleYear
Opioid Withdrawal Precipitated by Long-Acting Antagonists.
    The Journal of emergency medicine, 2020, Volume: 58, Issue:2

    Topics: Drug Combinations; Emergency Service, Hospital; Humans; Morphine; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Substance Withdrawal Syndrome

2020
Management of precipitated opiate withdrawal syndrome induced by nalmefene mistakenly prescribed in opiate-dependent patients: a review for clinicians.
    Expert opinion on drug metabolism & toxicology, 2017, Volume: 13, Issue:6

    Topics: Alcoholism; Analgesics, Opioid; Animals; Drug Interactions; Humans; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Risk Factors; Substance Withdrawal Syndrome

2017
Opioid antagonists under heavy sedation or anaesthesia for opioid withdrawal.
    The Cochrane database of systematic reviews, 2010, Jan-20, Issue:1

    Topics: Anesthetics; Humans; Hypnotics and Sedatives; Naloxone; Naltrexone; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Randomized Controlled Trials as Topic; Substance Withdrawal Syndrome

2010

Trials

3 trial(s) available for nalmefene and Addiction, Opioid

ArticleYear
Assessment of nalmefene glucuronide as a selective gut opioid antagonist.
    Drug and alcohol dependence, 1995, Volume: 39, Issue:2

    Topics: Adult; Arousal; Autonomic Nervous System; Constipation; Dose-Response Relationship, Drug; Gastrointestinal Motility; Humans; Male; Methadone; Naltrexone; Narcotic Antagonists; Neurologic Examination; Opioid-Related Disorders; Substance Withdrawal Syndrome

1995
Rapid opioid detoxification during general anesthesia: a review of 20 patients.
    Anesthesiology, 1999, Volume: 91, Issue:6

    Topics: Adult; Anesthesia, General; Combined Modality Therapy; Female; Humans; Male; Middle Aged; Monitoring, Physiologic; Naloxone; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Substance Withdrawal Syndrome

1999
Nalmefene: blockade of intravenous morphine challenge effects in opioid abusing humans.
    Drug and alcohol dependence, 2000, Jul-01, Volume: 60, Issue:1

    Topics: Adult; Analysis of Variance; Cross-Over Studies; Double-Blind Method; Humans; Injections, Intravenous; Male; Morphine; Naltrexone; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Pupil

2000

Other Studies

6 other study(ies) available for nalmefene and Addiction, Opioid

ArticleYear
Standard binding and functional assays related to medications development division testing for potential cocaine and opiate narcotic treatment medications.
    NIDA research monograph, 1998, Volume: 178

    Topics: Animals; Aorta, Thoracic; Cocaine; Cyclic AMP; Electric Stimulation; Guinea Pigs; Humans; Ileum; In Vitro Techniques; Male; Mice; Muscle, Smooth; Opioid-Related Disorders; Rats; Receptors, Dopamine; Receptors, Opioid; Receptors, Serotonin; Substance-Related Disorders

1998
Severe opioid withdrawal syndrome after a single dose of nalmefene.
    European journal of clinical pharmacology, 2015, Volume: 71, Issue:8

    Topics: Adult; Alcoholism; Analgesics, Opioid; Codeine; Contraindications; Drug Interactions; Humans; Male; Methadone; Middle Aged; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Substance Withdrawal Syndrome

2015
[Nalmefene and Opioid Withdrawal Syndrome: Analysis of the Global Pharmacovigilance Database for Adverse Drug Reactions].
    Praxis, 2015, Oct-14, Volume: 104, Issue:21

    Topics: Adult; Adverse Drug Reaction Reporting Systems; Aged; Alcoholism; Humans; Male; Methadone; Middle Aged; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Oxycodone; Pharmacovigilance; Substance Withdrawal Syndrome

2015
Nalmefene Mistakenly Prescribed to Reduce Alcohol Consumption in Patients Under Buprenorphine Substitution Therapy Resulting in Acute Opioid Withdrawal: Management in an Emergency Setting.
    Journal of clinical psychopharmacology, 2016, Volume: 36, Issue:1

    Topics: Adult; Alcohol Drinking; Analgesics, Opioid; Buprenorphine; Drug Interactions; Female; Humans; Middle Aged; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Substance Withdrawal Syndrome

2016
Opioid-dependent anticipatory negative contrast and binge-like eating in rats with limited access to highly preferred food.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2008, Volume: 33, Issue:3

    Topics: Adiposity; Animals; Anxiety; Behavior, Animal; Body Weight; Eating; Feeding Behavior; Female; Food; Food Preferences; Ghrelin; Growth Hormone; Leptin; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Rats; Rats, Wistar

2008
International update: new findings on promising medications.
    Alcoholism, clinical and experimental research, 1996, Volume: 20, Issue:8 Suppl

    Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Animals; Clinical Trials as Topic; Cocaine; Comorbidity; Europe; Humans; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Taurine; United States

1996